Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,101–2,125 of 27,380 studies, newest first · page 85 of 1096.

December 2025 25

  1. 2025-12-22

    National trends in cerebrospinal fluid biomarker testing for Alzheimer's disease in Japan

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease reports

    Key finding: The annual number of health insurance claims for p-tau181 testing gradually increased from 1358 (2014) to 3420 (2023); 79-86% of claims were from inpatient settings throughout the study period. +4 more findings

  2. 2025-12-22

    Cerebral small vessel disease unveils a vascular pathway to motoric cognitive risk in aging

    ✓ Peer-reviewed Vascular contributions Journal of Alzheimer s Disease

    Key finding: In this multi-cohort study of older adults without cognitive impairment, we show that WMH and lacunes independently predict increased risk of MCR, after adjusting for key confounders. +4 more findings

  3. 2025-12-22

    Expanding the Boundaries of Palliative Care: Diseases of the Nervous System and Survival Prognosis in Home-Based Programs

    ✓ Peer-reviewed End-of-life care American Journal of Hospice and Palliative Medicine®

    Key finding: DNS conditions, particularly dementia, were associated with longer survival among non-oncologic HBPC patients. +3 more findings

  4. 2025-12-22

    The role of the MIND diet in Alzheimer's disease patients: A case-control study on malnutrition and depression

    ✓ Peer-reviewed Prevention trials Nutrition

    Key finding: These findings suggest that adherence to the MIND diet may support nutrition and psychological well-being in AD and highlight the value of integrating nutrition-based approaches into dementia care. +3 more findings

  5. 2025-12-22
  6. 2025-12-22
  7. 2025-12-22
  8. 2025-12-22

    Should we include dementia diagnosis or cognitive impairment to predict home care cost? : an observational study using real-world data

    ✓ Peer-reviewed Health systems and care delivery Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)

    Key finding: Among the 1,035 patients in our dataset, 176 (17%) had a dementia diagnosis. +4 more findings

  9. 2025-12-22
  10. 2025-12-22

    Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis

    ✓ Peer-reviewed Prevention and risk The Lancet Healthy Longevity

    Key finding: No significant association was found between MHT use and risk of mild cognitive impairment or dementia. +1 more finding

  11. 2025-12-20

    Fasted-State Aerobic Exercise Enhances Cognition and Hippocampal BDNF Signaling in an Alzheimer's Disease Rat Model

    ✓ Peer-reviewed Prevention trials Neurochemical research

    Key finding: Aβ injection significantly impaired learning and memory and reduced hippocampal levels of PKA, CREB, and BDNF (p < 0.001). +2 more findings

  12. 2025-12-20
  13. 2025-12-20

    Montreal Cognitive Assessment (MoCA) Scale: Strengths, Limitations, and Implication for Clinical Practice

    ✓ Peer-reviewed Getting a diagnosis Iranian Journal of Psychiatry

    Key finding: The MoCA shows superior sensitivity for MCI detection compared to the Mini-Mental State Examination (MMSE), with strengths in brevity, multidomain coverage, and accessibility. +4 more findings

  14. 2025-12-20

    Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study

    ✓ Peer-reviewed Prevention and risk Alzheimer's Research & Therapy

    Key finding: In the intention-to-treat analysis, dementia risk was not different between GLP1-RA and DPP4i initiators (hazard ratio [HR] 0.95, 95% confidence interval [CI] 0.87–1.04; rates: 6.29 versus 6.64 per 1000 person-years; mean follow-up: 6.54 years); however, continuous GLP1-RA versus DPP4i use was associated with a 21% lower risk (HR 0.79, 95% CI 0.64–0.97; rates: 3.64 versus 4.82; mean follow-up: 2.71 years). +3 more findings

  15. 2025-12-19

    Nanobody Therapeutics in Alzheimer's Disease: From Molecular Mechanisms to Translational Approaches

    ✓ Peer-reviewed Drug development Antibodies (Basel, Switzerland)

    Key finding: They offer distinct engineering benefits compared with traditional antibodies and small molecules, including small size, stability, and specificity. +1 more finding

  16. 2025-12-19

    Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia (New York, N. Y.)

    Key finding: Twenty-six percent of participants were PET positive. +4 more findings

  17. 2025-12-19

    Trem2R47H and reduced TREM2 expression both mimic human Alzheimer's disease signatures in mice

    ⚠ Preprint — not yet peer-reviewed TREM2 and immune genetics bioRxiv : the preprint server for biology

    Key finding: Trem2*R47H mice had alternative splicing leading to reduced Trem2 expression; Trem2*R47HHSS mice expressed Trem2 at wild-type transcript and protein levels. +3 more findings

    Scored 22 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2025-12-19

    γ-Secretase exosites as targets for substrate-selective lowering of Aβ generation

    ✓ Peer-reviewed Risk genes beyond APOE Structure

    Key finding: Moreover, we found that bulky aromatic mutations within the 16 amino acid extension of C99 interfere with exosite binding and inhibit substrate cleavage. +1 more finding

  19. 2025-12-19

    Delirium prevalence and incidence in acutely admitted older patients: an observational cohort study

    ✓ Peer-reviewed How common it is BMC Geriatrics

    Key finding: length of stay, need for a higher level of care, and mortality after discharge in patients with and without delirium. +4 more findings

  20. 2025-12-19

    Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021

    ✓ Peer-reviewed Disparities Neuroepidemiology

    Key finding: In 2021, the age-standardised rates for ADOD were 694.01 (95% uncertainty intervals [UIs]: 602.88 to 794.08) for prevalence, 119.76 (95% UI: 104.96 to 135.89) for incidence, and 481.70 (95% UI: 228.79 to 1,023.96) for disability-adjusted life years (DALYs). +4 more findings

  21. 2025-12-19

    Biología en la sangre: avances en biomarcadores plasmáticos para el diagnóstico de la enfermedad de Alzheimer

    ✓ Peer-reviewed Genetics Star of Sciences Multidisciplinary Journal

    Key finding: El cociente Aβ42/40 refleja con alta sensibilidad la carga amiloide cerebral, mientras que las isoformas p-tau181 y p-tau217 indican la propagación de la patología tau. +4 more findings

  22. 2025-12-19
  23. 2025-12-19

    A APOLIPOPROTEINA E (APOE) E SUAS ISOFORMAS NA DOENÇA DE ALZHEIMER

    ✓ Peer-reviewed Genetics Revista Contemporânea

    Key finding: A análise crítica dos estudos permitiu avaliar a relação entre a APOE, suas variantes e processos como deposição de β-amiloide, neuroinflamação, reparo sináptico e metabolismo lipídico. +4 more findings

  24. 2025-12-19

    Neighborhood environmental deprivation predicts the generalized neurocognitive deficit in schizophrenia

    ✓ Peer-reviewed Risk factors Schizophrenia Research

    Key finding: The effect of ADI score was also significant, β = -0.36, t = -2.30, p < .05; while the effect of RUCC, β = 0.06, t = 0.34, p = .73, and the interaction between ADI and RUCC, β = -0.001, t = 0.27, p = .99, were nonsignificant. +2 more findings

  25. 2025-12-18

    Genetic architecture of Alzheimer’s disease-related plasma biomarkers

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv

    Key finding: The observed phenotypic and genetic associations highlight shared underlying mechanisms among plasma biomarkers. +1 more finding

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →